Ibrutinib Treatment Shows Efficacy and Tolerability in Heavily Treated CLL Patients Following Allogeneic Stem Cell Transplant

[AussieNeil]

You have to admire Pharmacyclics advertising capability. Here they are showing how effective Ibrutinib (Imbruvica) is on a tough to treat bunch of CLL patients. "These patients had a median of five prior therapies and 63% were high-risk del 17p CLL patients. The estimated median progression-free survival (PFS) at 24 months was 76.6%. All patients had previously undergone allogeneic stem cell transplants."

pipelinereview.com/index.ph...

Neil

Photo: Some red eucalyptus blossoms

[Justasheet1]

It's nice to know there is still options after such a hellish road. Thank you. I needed that after that previous post about hospice. Keep the GOOD news coming.

Jeff

[AussieNeil Administrator in reply to Justasheet1]

Read Brian Koffman's blog some time, in particular the early entries:

bkoffman.blogspot.com.au/